Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on January 11, 2022. The report discloses a material amendment to the executive employment agreement of R. Scott Coffman, the Company's co-Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on executive compensation adjustments.
Material Changes
- Executive Compensation Reduction: Effective January 1, 2022, Mr. Coffman's annual base salary was reduced by $80,000, from $450,000 to $370,000 for the 2022 calendar year.
- Performance Contingency: The agreement includes a provision allowing Mr. Coffman to receive an annual compensation of $420,000 for 2022 if he and the Company mutually agree that the Company's performance has improved during the period. This would include payment of the previously reduced amount.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or specific risk factors beyond the context of the executive compensation adjustment. The salary reduction implies a potential need for cost management, while the performance clause suggests management's intent to align executive pay with future operational improvements.
Investor Verification Checklist
- Verify the full text of Exhibit 10.1 (Amendment No. 1) to understand specific performance metrics required to trigger the salary restoration.
- Review recent quarterly reports (10-Q) or annual reports (10-K) to assess the Company's current financial health and the rationale behind the salary reduction.
- Monitor subsequent filings for any further changes to executive compensation or indications of operational performance improvements.